The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

NCT03058757 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER_GOV

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: intravesical mitomycin-C 40mg/20ml instillation

Sponsor

National Cancer Center, Korea